Bharat Parenterals Declares Unaudited Q1 FY27 Results

Bharat Parenterals Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results along with the Limited Review Report and Management Discussion and Analysis Report. The company also fixed the date for its 33rd Annual General Meeting as September 19, 2026, and approved related meeting documents. Additionally, the re-appointment of Mr. Hemang Shah as Executive Director for a five-year term was approved, subject to shareholder approval.